-
A Speciality Pharmaceutical Organization -
Supporting Partners from Early Formulations to Commercialization -
Where Research Meets Innovation -
Highly Potent and Oncology Products -
> First to File Product Development
> Product Development by Para-IV Strategy
> Product Development by 505(b)(2) Strategy
> Peptide Injectables
> Prefilled Syringes
> Lyophilized InjectablesExpertise :
IDRS Labs – a specialty pharmaceutical organization, is a leading product development partner to pharmaceutical organizations globally. IDRS has a proven track record across domains, forging and nurturing strategic, long-term partnerships with pharmaceutical leaders, with a goal of enhancing therapeutic value of products for consumers, and building success for stakeholders. We have helped our clients develop products – from injectables to orals, which have been a commercial success in global markets, and are a testimony to our expertise and experience as a research, development and growth partner.
Shivkumar, a trained Clinical Pharmacist, brings significant experience in core clinical research. He has been involved in conducting multiple clinical trials in various indications for India and global registrations. He has experience in conducting Phase-II to IV clinical trials for small molecules and bio-similars.
Mahendra Joshi brings significant experience in solid and liquid oral formulation development. He has experience in setting up the formulation laboratory and in establishing the systems for preformulation and NCE product development. He has successfully developed drug products for global pharma majors to support IND, CTA, NDA and ANDA fillings.
Yogesh is an entrepreneur who has been a part of many successful ventures in the pharmaceutical industry. He brings substantial experience to IDRS in areas of Finance, Business Strategy and Operations (including logistics and supply chain management).
Pradeep brings significant expertise in formulation research and development, process characterization, scale-up and clinical supplies manufacturing. His experience spans developing formulations for NCEs, NDAs and generics.